Green James W's Form 4 filing
Harvard Bioscience Inc (HBIO) · filed Mar 15, 2023
- Accession no.
- 0000921895-23-000690
- Filed
- Mar 15, 2023
- Trade date
- Mar 14-15, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $105.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Green James WCIK 0001400121 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Common Stock | PPurchaseAcquired | +20,000 | $2.67 | +$53,400 | 2,866,052 | Direct | |
| Mar 15, 2023 | Common Stock | PPurchaseAcquired | +20,000 | $2.60 | +$52,000 | 2,886,052 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.